Prognostic value analysis of mutational and clinicopathological factors in non-small cell lung cancer.
Targeting activating oncogenic driver mutations in lung adenocarcinoma has led to prolonged survival in patients harboring these specific genetic alterations. The prognostic value of these mutations has not yet been elucidated. The prevalence of recently uncovered non-coding somatic mutation in prom...
Main Authors: | Chenguang Li, Ligang Hao, Yue Li, Shengguang Wang, Hui Chen, Lianmin Zhang, Bin Ke, Yuesong Yin, Haijin Suo, Bingsheng Sun, Bin Zhang, Changli Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4157862?pdf=render |
Similar Items
-
PinX1 Is a Potential Prognostic Factor for Non-Small-Cell Lung Cancer and Inhibits Cell Proliferation and Migration
by: Shengguang Wang, et al.
Published: (2017-01-01) -
Prognostic Significance of Combination of Preoperative Platelet Count and Neutrophil-Lymphocyte Ratio (COP-NLR) in Patients with Non-Small Cell Lung Cancer: Based on a Large Cohort Study.
by: Hua Zhang, et al.
Published: (2015-01-01) -
Prognostic significance of combined fibrinogen concentration and neutrophil-to-lymphocyte ratio in patients with resectable non-small cell lung cancer
by: Wuhao Huang, et al.
Published: (2018-03-01) -
Development of a novel prognostic score combining clinicopathologic variables, gene expression, and mutation profiles for lung adenocarcinoma
by: Guofeng Li, et al.
Published: (2020-09-01) -
The prognostic value of the preoperative albumin to alkaline phosphatase ratio in patients with non‐small cell lung cancer after surgery
by: Lianmin Zhang, et al.
Published: (2019-07-01)